Synaptosomal dopamine uptake in rat striatum following controlled cortical impact

Journal of Neuroscience Research

Volumn 80, Issue 1, 2005, Pages 85-91

  Wilson, Margaret S ^a,b   Chen, Xiangbai ^a,b   Ma, Xiecheng ^a,b   Ren, Dianxu ^c   Wagner, Amy K ^a,b   Reynolds, Ian J ^b   Dixon, C Edward ^a,b,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d NONE   (United States)

Author keywords

Dopamine; Radioligand binding; Rat; Striatum; Transporter; Traumatic brain injury; Western blotting

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; RADIOLIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MODEL; DOPAMINE UPTAKE; LIGAND BINDING; MALE; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RAT STRAIN; SYNAPTOSOME; WESTERN BLOTTING;

ADRENERGIC AGENTS; ANIMALS; BLOTTING, WESTERN; BRAIN INJURIES; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; KINETICS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES;

EID: 17744363493     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20419     Document Type: Article

References (33)

1. Berman SB, Zigmond MJ, Hastings TG. 1996. Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J Neurochem 67:593-600.
2. Dietrich WD, Alonso O, Busto R, Prado R, Zhao W, Dewanjee MK, Ginsberg MD. 1998. Posttraumatic cerebral ischemia after fluid percussion brain injury: an autoradiographic and histopathological study in rats. Neurosurgery 43:585-593; discussion 593-584.
3. Ding Y, Yao B, Lai Q, McAllister JP. 2001. Impaired motor learning and diffuse axonal damage in motor and visual systems of the rat following traumatic brain injury. Neurol Res 23:193-202.
4. Dixon CE, Clifton GL, Lighthall JW, Yaghmai AA, Hayes RL. 1991. A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Methods 39:253-262.
5. Dixon CE, Kraus MF, Kline AE, Ma X, Yan HQ, Griffith RG, Wolfson BM, Marion DW. 1999. Amantadine improves water maze performance without affecting motor behavior following traumatic brain injury in rats. Restor Neurol Neurosci 14:285-294.
6. 123I-IBZM. Eur J Nucl Med 27:1410-1414.
7. Dunn-Meynell AA, Levin BE. 1997. Histological markers of neuronal, axonal and astrocytic changes after lateral rigid impact traumatic brain injury. Brain Res 761:25-41.
8. Faden AI, Demediuk P, Panter SS, Vink R. 1989. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:798-800.
9. Fahn S, Cohen G. 1992. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32:804-812.
10. Hamm RJ, Dixon CE, Gbadebo DM, Singha AK, Jenkins LW, Lyeth BG, Hayes RL. 1992. Cognitive deficits following traumatic brain injury produced by controlled cortical impact. J Neurotrauma 9:11-20.
11. Hayes RL, Jenkins LW, Lyeth BG. 1992. Neurotransmitter-mediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids. J Neurotrauma 9(Suppl 1):S173-S187.
12. Kampfl A, Schmutzhard E, Franz G, Pfausler B, Haring HP, Ulmer H, Felber S, Golaszewski S, Aichner F. 1998. Prediction of recovery from post-traumatic vegetative state with cerebral magnetic-resonance imaging. Lancet 351:1763-1767.
13. Kline AE, Van HQ, Bao J, Marion DW, Dixon CE. 2000. Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neurosci Lett 280:163-166.
14. Kline AE, Massucci JL, Marion DW, Dixon CE. 2002. Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J Neurotrauma 19:415-425.
15. Kmieciak-Kolada K, Felinska W, Stachura Z, Majchrzak H, Herman ZS. 1987. Concentration of biogenic amines and their metabolites in different parts of brain after experimental cerebral concussion. Pol J Pharmacol Pharm 39:47-53.
16. Langston JW, Irwin I. 1986. MPTP: current concepts and controversies. Clin Neuropharmacol 9:485-507.
17. Mahalick DM, Carmel PW, Greenberg JP, Molofsky W, Brown JA, Heary RF, Marks D, Zampella E, Hodosh R, von der Schmidt E 3rd. 1998. Psychopharmacologic treatment of acquired attention disorders in children with brain injury. Pediatr Neurosurg 29:121-126.
18. McDowell S, Whyte J, D'Esposito M. 1998. Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 121:1155-1164.
19. McIntosh TK, Yu T, Gennarelli TA. 1994. Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J Neurochem 63:1426-1433.
20. McIntosh TK, Smith DH, Meaney DF, Kotapka MJ, Gennarelli TA, Graham DI. 1996. Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab Invest 74:315-342.
21. Metchaler JM, Brunner RC, Johnson A, Novack TA. 2002. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil 17:300-313.
22. Miller GW, Gainetdinov RR, Levey AI, Caron MG. 1999. Dopamine transporters and neuronal injury. Trends Pharmacol Sci 20:424-429.
23. Paxinos G, Watson C. 1982. The rat brain in stereotaxic coordinates. New York: Academic Press.
24. Plenger PM, Dixon CE, Castillo RM, Frankowski RF, Yablon SA, Levin HS. 1996. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil 77:536-540.
25. Reith ME, Xu C, Chen NH. 1997. Pharmacology and regulation of the neuronal dopamine transporter. Eur J Pharmacol 324:1-10.
26. Shohami E, Beit-Yannai E, Horowitz M, Kohen R. 1997. Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome. J Cereb Blood Flow Metab 17:1007-1019.
27. Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T. 2001. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci 21:4427-4435.
28. Tyurin VA, Tyurina YY, Borisenko GG, Sokolova TV, Ritov VB, Quinn PJ, Rose M, Kochanek P, Graham SH, Kagan VE. 2000. Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates. J Neurochem 75:2178-2189.
29. Whyte J, Hart T, Schuster K, Fleming M, Polansky M, Coslett HB. 1997. Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial. Am J Phys Med Rehabil 76:440-450.
30. Whyte J, Vaccaro M, Grieb-Neff P, Hart T. 2002. Psychostimulant use in the rehabilitation of individuals with traumatic brain injury. J Head Trauma Rehabil 17:284-299.
31. Van HQ, Kline AE, Ma X, Hooghe-Peters EL, Marion DW, Dixon CE. 2001. Tyrosine hydroxylase, but not dopamine beta-hydroxylase, is increased in rat frontal cortex after traumatic brain injury. Neuroreport 12:2323-2327.
32. Van HQ, Kline AE, Ma X, Li Y, Dixon CE. 2002. Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex. Neuroreport 13:1899-1901.
33. Zhu J, Hamm RJ, Reeves TM, Povlishock JT, Phillips LL. 2000. Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury. Exp Neurol 166:136-152.